Upregulation of Protein Phosphatase 2A and NR3A-Pleiotropic Effect of Simvastatin on Ischemic Stroke Rats

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Zhu, Minxia ^a,b   Wang, Jin ^a   Liu, Min ^a   Du, Dongshu ^a   Xia, Chunmei ^a   Shen, Linlin ^a   Zhu, Danian ^a  

^a FUDAN UNIVERSITY   (China)

^b XIZANG MINZU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 3A; OKADAIC ACID; PHOSPHOPROTEIN PHOSPHATASE 2A; SERINE; SIMVASTATIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION; BRAIN INFARCTION SIZE; BRAIN INJURY; BRAIN ISCHEMIA; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME INHIBITION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NEUROMODULATION; NEUROPROTECTION; NONHUMAN; PLEIOTROPY; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SINGLE DRUG DOSE; TREATMENT OUTCOME; UPREGULATION;

ANIMALS; BRAIN ISCHEMIA; CA1 REGION, HIPPOCAMPAL; GENE EXPRESSION REGULATION; GENETIC PLEIOTROPY; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; OKADAIC ACID; PHOSPHORYLATION; PROTEIN PHOSPHATASE 2; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; RNA, MESSENGER; SIMVASTATIN; STROKE; UP-REGULATION;

RATTUS;

EID: 84870868461     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0051552     Document Type: Article

References (34)

1. Laufs U, Liao JK, (2003) Rapid effects of statins: from prophylaxis to therapy for ischemic stroke. Arterioscler Thromb Vasc Biol 23: 156-157.
2. Khalessi AA, (2011) Stroke and the Neurosurgeon: supplement to WORLD NEUROSURGERY. World Neurosurg 76: 248-249.
3. Kostandy BB, (2011) The role of glutamate in neuronal ischemic injury: the role of spark in fire. Neurol Sci 33: 223-237.
4. Szydlowska K, Tymianski M, (2010) Calcium, ischemia and excitotoxicity. Cell Calcium 47: 122-129.
5. Kemp JA, McKernan RM, (2002) NMDA receptor pathways as drug targets. Nat Neurosci 5Suppl: 1039-1042.
6. Cui L, Zhang X, Yang R, Wang L, Liu L, et al. (2010) Neuroprotection of early and short-time applying atorvastatin in the acute phase of cerebral ischemia: down-regulated 12/15-LOX, p38MAPK and cPLA2 expression, ameliorated BBB permeability. Brain Res 1325: 164-173.
7. Laufs U, Gertz K, Huang P, Nickenig G, Bohm M, et al. (2000) Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice. Stroke 31: 2442-2449.
8. Berger C, Xia F, Maurer MH, Schwab S, (2008) Neuroprotection by pravastatin in acute ischemic stroke in rats. Brain Res Rev 58: 48-56.
9. Szczepanska-Szerej A, Kurzepa J, Wojczal J, Stelmasiak Z, (2007) Simvastatin-induced prevention of the increase in TNF-alpha level in the acute phase of ischemic stroke. Pharmacol Rep 59: 94-97.
10. Sierra S, Ramos MC, Molina P, Esteo C, Vazquez JA, et al. (2011) Statins as neuroprotectants: a comparative in vitro study of lipophilicity, blood-brain-barrier penetration, lowering of brain cholesterol, and decrease of neuron cell death. J Alzheimers Dis 23: 307-318.
11. Liao JK, Laufs U, (2005) Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol 45: 89-118.
12. Sucher NJ, Akbarian S, Chi CL, Leclerc CL, Awobuluyi M, et al. (1995) Developmental and regional expression pattern of a novel NMDA receptor-like subunit (NMDAR-L) in the rodent brain. J Neurosci 15: 6509-6520.
13. Ciabarra AM, Sullivan JM, Gahn LG, Pecht G, Heinemann S, et al. (1995) Cloning and characterization of chi-1: a developmentally regulated member of a novel class of the ionotropic glutamate receptor family. J Neurosci 15: 6498-6508.
14. Sasaki YF, Rothe T, Premkumar LS, Das S, Cui J, et al. (2002) Characterization and comparison of the NR3A subunit of the NMDA receptor in recombinant systems and primary cortical neurons. J Neurophysiol 87: 2052-2063.
15. Chatterton JE, Awobuluyi M, Premkumar LS, Takahashi H, Talantova M, et al. (2002) Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits. Nature 415: 793-798.
16. Lechward K, Awotunde OS, Swiatek W, Muszynska G, (2001) Protein phosphatase 2A: variety of forms and diversity of functions. Acta Biochim Pol 48: 921-933.
17. Bononi A, Agnoletto C, De Marchi E, Marchi S, Patergnani S, et al. (2011) Protein kinases and phosphatases in the control of cell fate. Enzyme Res 2011: 1-26.
18. Wang LY, Orser BA, Brautigan DL, MacDonald JF, (1994) Regulation of NMDA receptors in cultured hippocampal neurons by protein phosphatases 1 and 2A. Nature 369: 230-232.
19. Skeberdis VA, Chevaleyre V, Lau CG, Goldberg JH, Pettit DL, et al. (2006) Protein kinase A regulates calcium permeability of NMDA receptors. Nat Neurosci 9: 501-510.
20. Chan SF, Sucher NJ, (2001) An NMDA receptor signaling complex with protein phosphatase 2A. J Neurosci 21: 7985-7992.
21. Ma OK, Sucher NJ, (2004) Molecular interaction of NMDA receptor subunit NR3A with protein phosphatase 2A. Neuroreport 15: 1447-1450.
22. Longa EZ, Weinstein PR, Carlson S, Cummins R, (1989) Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20: 84-91.
23. Montaner J, (2005) Treatment with statins in the acute phase of ischemic stroke. Expert Rev Neurother 5: 211-221.
24. Garcia-Bonilla L, Campos M, Giralt D, Salat D, Chacon P, et al. (2012) Evidence for the efficacy of statins in animal stroke models: a meta-analysis. J Neurochem 122: 233-243.
25. Tingley WG, Ehlers MD, Kameyama K, Doherty C, Ptak JB, et al. (1997) Characterization of protein kinase A and protein kinase C phosphorylation of the N-methyl-D-aspartate receptor NR1 subunit using phosphorylation site-specific antibodies. J Biol Chem 272: 5157-5166.
26. MacDonald JF, Mody I, Salter MW, (1989) Regulation of N-methyl-D-aspartate receptors revealed by intracellular dialysis of murine neurones in culture. J Physiol 414: 17-34.
27. Bickler PE, Fahlman CS, Ferriero DM, (2004) Hypoxia increases calcium flux through cortical neuron glutamate receptors via protein kinase C. J Neurochem. 88: 878-884.
28. Cheung HH, Teves L, Wallace MC, Gurd JW, (2001) Increased phosphorylation of the NR1 subunit of the NMDA receptor following cerebral ischemia. J Neurochem 78: 1179-1182.
29. Besshoh S, Bawa D, Teves L, Wallace MC, Gurd JW, (2005) Increased phosphorylation and redistribution of NMDA receptors between synaptic lipid rafts and post-synaptic densities following transient global ischemia in the rat brain. J Neurochem 93: 186-194.
30. Yi KD, Simpkins JW, (2008) Protein phosphatase 1, protein phosphatase 2A, and calcineurin play a role in estrogen-mediated neuroprotection. Endocrinology 149: 5235-5243.
31. Nakanishi N, Tu S, Shin Y, Cui J, Kurokawa T, et al. (2009) Neuroprotection by the NR3A subunit of the NMDA receptor. J Neurosci 29: 5260-5265.
32. Mueller HT, Meador-Woodruff JH, (2004) NR3A NMDA receptor subunit mRNA expression in schizophrenia, depression and bipolar disorder. Schizophr Res 71: 361-370.
33. Henson MA, Roberts AC, Salimi K, Vadlamudi S, Hamer RM, et al. (2008) Developmental regulation of the NMDA receptor subunits, NR3A and NR1, in human prefrontal cortex. Cereb Cortex 18: 2560-2573.
34. Bialojan C, Takai A, (1988) Inhibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases. Specificity and kinetics. Biochem J 256: 283-290.